Literature DB >> 2884483

Apomorphine infusion for motor fluctuations in Parkinson's disease.

J A Obeso, F Grandas, J Vaamonde, M Rosario Luguin, J M Martínez-Lage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2884483     DOI： 10.1016/s0140-6736(87)90679-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?

Authors:  L Dépatie; S Lal
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Subcutaneous apomorphine in Parkinson's disease.

Authors:  P Pollak; A S Champay; M Hommel; J E Perret; A L Benabid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

3.  Continuous subcutaneous apomorphine infusion in advanced Parkinson's disease: 10-year experience with 230 patients.

Authors:  Ángel Sesar; Gustavo Fernández-Pajarín; Begoña Ares; María Teresa Rivas; Alfonso Castro
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

4.  Deep brain stimulation of the subthalamic nucleus: effectiveness in advanced Parkinson's disease patients previously reliant on apomorphine.

Authors:  T R K Varma; S H Fox; P R Eldridge; P Littlechild; P Byrne; A Forster; A Marshall; H Cameron; K McIver; N Fletcher; M Steiger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

5.  Apomorphine pharmacokinetics in parkinsonism after intranasal and subcutaneous application.

Authors:  E Sam; A P Jeanjean; J M Maloteaux; N Verbeke
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Jan-Mar       Impact factor: 2.441

6.  Subcutaneous apomorphine infusion in Parkinson's disease: does it have a role?

Authors:  K A Muhiddin; M T Roche; V R Pearce
Journal:  Postgrad Med J       Date:  1994-05       Impact factor: 2.401

7.  Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up.

Authors:  K Pietz; P Hagell; P Odin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

Review 8.  Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Clin Drug Investig       Date:  2018-04       Impact factor: 2.859

Review 9.  Apomorphine effects on the hippocampus.

Authors:  Luis Enrique Arroyo-Garcia; Antonio Rodríguez-Moreno; Gonzalo Flores
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.